Orchid Pharma Limited - Company Profile

It is a pharma public limited company based in Chengalpattu, Tamil Nadu, India, established in 1992.
1992 Chengalpattu, Tamil Nadu, India Active
Last Updated:
Access Report
About Orchid Pharma Limited

Orchid Pharma Limited, a active public limited company, was established on 01 July 1992 in Chengalpattu, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24222TN1992PLC022994. Registered under ROC Roc Chennai. it is listed on BSE: 524372 and NSE: BE : ORCHPHARMA. It has an authorized capital of ₹150.00 Cr and a paid-up capital of ₹50.72 Cr.

Formerly known as Orchid Chemicals & Pharmaceuticals Limited. It upholds a compliant status. In 2024, it reported revenue of ₹849.76 Cr and a net worth of ₹1,218.32 Cr. Employing 1,101 professional, Its leadership includes Mridul Dhanuka (Whole-Time Director), Arjun Dhanuka (Director), Tanu Singla (Director). Past directors included Soundara Kumar, Sundaram Yuvaraj, Maligail Ramkrishna Girinath. It holds ₹366.50 Cr open charges and ₹15,353.51 Cr settled loans. Its latest AGM occurred on 20 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No 121-128, 128A-133, 138-151, 159-164, Sidco Industrial Estate,Alathur,Chengalpattu, Chengalpattu, Tamil Nadu, 603110.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L24222TN1992PLC022994

  • Registration Number

    022994

  • Incorporation Date

    01 July 1992

  • Authorized Capital

    ₹150.00 Cr

  • Paid-Up Capital

    ₹50.72 Cr

  • ROC Code

    Roc Chennai

  • Listing Status

    Listed (BSE: 524372, NSE: BE : ORCHPHARMA)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 150.00 Cr
  • Paid Up Capital ₹ 50.72 Cr
  • Company Age 33 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 366.50 Cr
  • Satisfied Charges ₹ 15,353.51 Cr
  • Revenue Growth **** 23.99%
  • Profit Growth **** 74.85%
  • Ebitda **** 32.36%
  • Net Worth 66.45%
  • Total Assets **** 26.89%
Company report

Orchid Pharma Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Orchid Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Orchid Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Mridul Dhanuka Whole-Time Director 31 Mar 2020 Current
Arjun Dhanuka Director 20 Oct 2023 Current
Tanu Singla Director 29 Jun 2020 Current
Dharam Vir Director 29 Jun 2020 Current
Manish Dhanuka Managing Director 31 Mar 2020 Current
Shubha Singh Director 23 May 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Nominee Director 10 Sep 2018 Past
Pramod Abcsdd Director 28 May 2015 Past
Pramod Abcsdd Director 29 Jul 2011 Past
Pramod Abcsdd Additional Director 29 Jun 2020 Past
Pramod Abcsdd Additional Director 15 Sep 2015 Past
Pramod Abcsdd Managing Director 01 Nov 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Orchid Pharma.

Orchid Pharma Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 23.99% increase. The company also saw a substantial improvement in profitability, with a 74.85% increase in profit. The company's net worth Soared by an impressive increase of 66.45%.

Orchid Pharma revenue growth over time
Orchid Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 23.99%
*******
*******
*******
*******
Revenue from Operations
*******
 23.05%
*******
*******
*******
*******
Total Assets
*******
 26.89%
*******
*******
*******
*******
Profit or Loss
*******
 74.85%
*******
*******
*******
*******
Net Worth
*******
 66.45%
*******
*******
*******
*******
EBITDA
*******
 32.36%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Orchid Pharma?

In 2024, Orchid Pharma had a promoter holding of 69.84% and a public holding of 30.16%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,665,000,000.00

Satisfied Charges

₹153,535,142,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 291.50 Cr
  • Yes Bank Limited : 75.00 Cr
Latest Charge Details
Date Lender Amount Status
17 Jul 2025 Hdfc Bank Limited ₹142.50 Cr Open
27 Aug 2022 Yes Bank Limited ₹75.00 Cr Open
15 Nov 2021 Hdfc Bank Limited ₹149.00 Cr Open
02 Aug 2023 Hdfc Bank Limited ₹50.00 Cr Satisfied
06 Jul 2020 Others ₹229.67 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Orchid Pharma?

Orchid Pharma has a workforce of 1101 employees as of Nov 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Orchid Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orchid Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Orchid Pharma
Recent Activity within the Organization
  • Charges

    A charge with Hdfc Bank Limited of Rs. 142.50 Cr registered on 17 Jul 2025 with Charge ID 101132171 was modified on 08 Oct 2025. was recorded as a recent event.

  • Annual General Meeting

    Progress on Orchid Pharma Limited last Annual general meeting of members was held on 20 Sep 2025 as per latest MCA records. was documented.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 142.50 Cr with Charge ID 101132171 was registered on 17 Jul 2025. was documented.

  • Balance Sheet

    The activity Orchid Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was completed.

  • Director Appointment

    Shubha Singh was appointed as a Director was appointed as a Director on 23 May 2024 & has been associated with this company since 1 year 8 months . was recorded as a recent event.

  • Charges

    A charge with Yes Bank Limited of Rs. 75.00 Cr registered on 27 Aug 2022 with Charge ID 100615515 was modified on 10 Jan 2024. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Orchid Pharma Limited?

The CIN of Orchid Pharma Limited is L24222TN1992PLC022994.

Where is Orchid Pharma Limited headquartered?

Orchid Pharma Limited is headquartered at Plot No 121-128, 128A-133, 138-151, 159-164, Sidco Industrial Estate,Alathur,Chengalpattu, Chengalpattu, Tamil Nadu, 603110.

When was Orchid Pharma Limited incorporated?

Orchid Pharma Limited was incorporated on 01 July 1992.

Who are the current directors of Orchid Pharma Limited?

The current directors of Orchid Pharma Limited are

What is the primary industry of Orchid Pharma Limited?

The primary industry of Orchid Pharma Limited is Manufacturing.

Is Orchid Pharma Limited a listed company?

Orchid Pharma Limited is listed. It is listed on BSE: 524372 and NSE: BE : ORCHPHARMA.

What is the capital structure of Orchid Pharma Limited?

The authorized capital of Orchid Pharma Limited is ₹150.00 Cr, and the paid-up capital is ₹50.72 Cr.

What is the compliance status of Orchid Pharma Limited?

The compliance status of Orchid Pharma Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available